title: Analysis of TBX1 variation in patients with psychotic and affective disorders.
abstract: A significant portion of patients with 22q11 deletion syndrome (22q11DS) develop psychiatric disorders, including schizophrenia and other psychotic and affective symptoms, and the responsible gene/s are assumed to also play a significant role in the etiology of nonsyndromic psychiatric disease. The most common psychiatric diagnosis among patients with 22q11DS is schizophrenia, thought to result from neurotransmitter imbalances and also from disturbed brain development. Several genes in the 22q11 region with known or suspected roles in neurotransmitter metabolism have been analyzed in patients with isolated schizophrenia; however, their contribution to the disease remains controversial. Haploinsufficiency of the TBX1 gene has been shown to be sufficient to cause the core physical malformations associated with 22q11DS in mice and humans and via abnormal brain development could contribute to 22q11DS-related and isolated psychiatric disease. 22q11DS populations also have increased rates of psychiatric conditions other than schizophrenia, including mood disorders. We therefore analyzed variations at the TBX1 locus in a cohort of 446 white patients with psychiatric disorders relevant to 22q11DS and 436 ethnically matched controls. The main diagnoses included schizophrenia (n = 226), schizoaffective disorder (n = 67), bipolar disorder (n = 82), and major depressive disorder (n = 29). We genotyped nine tag SNPs in this sample but did not observe significant differences in allele or haplotype frequencies in any of the analyzed groups (all affected, schizophrenia and schizoaffective disorder, schizophrenia alone, and bipolar disorder and major depressive disorder) compared with the control group. Based on these results we conclude that TBX1 variation does not make a strong contribution to the genetic etiology of nonsyndromic forms of psychiatric disorders commonly seen in patients with 22q11DS.
authors.affiliation: Harvard Partners Center for Genetics and Genomics, Boston, MA 02139, USA. bfunke@partners.org
authors.forename: Birgit H
authors.initials: BH
authors.lastname: Funke
authors.forename: Todd
authors.initials: T
authors.lastname: Lencz
authors.forename: Christine T
authors.initials: CT
authors.lastname: Finn
authors.forename: Pamela
authors.initials: P
authors.lastname: DeRosse
authors.forename: G David
authors.initials: GD
authors.lastname: Poznik
authors.forename: Alex M
authors.initials: AM
authors.lastname: Plocik
authors.forename: John
authors.initials: J
authors.lastname: Kane
authors.forename: John
authors.initials: J
authors.lastname: Rogus
authors.forename: Anil K
authors.initials: AK
authors.lastname: Malhotra
authors.forename: Raju
authors.initials: R
authors.lastname: Kucherlapati
mesh_terms: D000328:Adult; D002872:Chromosome Deletion; D002892:Chromosomes, Human, Pair 22 / Q000235:genetics; D005260:Female; D006239:Haplotypes; D006801:Humans; D008297:Male; D019964:Mood Disorders / Q000235:genetics*; D020641:Polymorphism, Single Nucleotide; D011618:Psychotic Disorders / Q000235:genetics*; D020825:T-Box Domain Proteins / Q000235:genetics*
chemical_list: D020825:T-Box Domain Proteins; C108625:TBX1 protein, human